ArticleBioprocess and biosystems engineering2026
Current challenges and future directions in the green synthesis of nanoparticles using fungi.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungi have historically played a significant role in advancing biotechnology and are now increasingly recognized as flexible platforms for eco-friendly nanoparticle production. Nonetheless, progress has been hindered by inconsistent methodologies, limited mechanistic understanding, and reproducibility issues. Unlike earlier reviews, this study comprehensively analyzes a decade of research (2015-2025) to link fungal species diversity, biosynthesis pathways, and experimental setups to nanoparticle formation. It highlights the crucial roles of enzymatic activity and secreted metabolites in determining nanoparticle shape and stability. The study demonstrates that variables such as culture medium, pH, incubation period, and downstream processes are not minor technical details but key factors influencing nanoparticle size, morphology, and stability. Additionally, there is a strong taxonomic bias toward a narrow set of filamentous fungi and a material bias toward silver, gold, and zinc, despite the broader biosynthetic potential of the fungal kingdom and the growing relevance of unexplored metals, including critical metals (e.g., Nb, Zr, and V). By combining mechanistic insights with advanced transcriptomic, proteomic, metabolomic, and genomic data, myconanotechnology can move toward a predictive framework based on metal stress responses, secreted biomolecules, and redox metabolism. Achieving this shift is critical to improving reproducibility, scaling up production, and developing rational approaches to the creation of fungal nanomaterials for biomedical, environmental, and industrial applications.
Indexed as
Identifiers
42776243What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.